Literature DB >> 6409108

Human plasma proapoA-I: isolation and amino-terminal sequence.

H B Brewer, T Fairwell, L Kay, M Meng, R Ronan, S Law, J A Light.   

Abstract

Human apoA-I is synthesized as preproapoA-I, a 267 amino acid precursor apolipoprotein. PreproapoA-I initially undergoes intracellular co-translational proteolytic cleavage into proapoA-I. ProapoA-I is secreted from the cell and was isolated from thoracic duct lymph in the apoA-I1 isoform position. The amino-terminal sequence of proapoA-I isolated from human lymph revealed the presence of 6 additional amino acids, Arg-His-Phe-Trp-Gln-Gln, on the amino-terminal end of apoA-I consistent with the proapoA-I sequence determined by nucleic acid sequence analysis of cloned apoA-I. Our results indicate that proapoA-I is present in human plasma, and undergoes post-translational proteolytic cleavage to mature plasma apoA-I.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6409108     DOI: 10.1016/0006-291x(83)91772-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Cubbing in proapolipoprotein maturation.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2011-09-06       Impact factor: 5.922

2.  In vivo metabolism of proapolipoprotein A-I in Tangier disease.

Authors:  D Bojanovski; R E Gregg; L A Zech; M S Meng; C Bishop; R Ronan; H B Brewer
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

3.  Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA.

Authors:  S W Law; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

Review 4.  Potential biomarkers in psychiatry: focus on the cholesterol system.

Authors:  Alisa G Woods; Izabela Sokolowska; Regina Taurines; Manfred Gerlach; Edward Dudley; Johannes Thome; Costel C Darie
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

Review 5.  Role of Apolipoproteins and α-Synuclein in Parkinson's Disease.

Authors:  Fatemeh Nouri Emamzadeh
Journal:  J Mol Neurosci       Date:  2017-07-10       Impact factor: 3.444

Review 6.  Parkinson's Disease: Biomarkers, Treatment, and Risk Factors.

Authors:  Fatemeh N Emamzadeh; Andrei Surguchov
Journal:  Front Neurosci       Date:  2018-08-30       Impact factor: 4.677

Review 7.  The Positive Side of the Alzheimer's Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1.

Authors:  Lidia Ciccone; Chenghui Shi; Davide di Lorenzo; Anne-Cécile Van Baelen; Nicolo Tonali
Journal:  Molecules       Date:  2020-05-23       Impact factor: 4.411

Review 8.  What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?

Authors:  Mary G Sorci-Thomas; Ricquita D Pollard; Michael J Thomas
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.